Arkolith/Insider Trading/EBS/Form 4

Lowry Simon C

SVP, R&D, CMOEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Tax withholding(F)11K$8.44$90K78K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)45K—$0148K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002044279-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML